| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96c558861edfefb224298c89ee54b00d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-74 |
| filingDate |
2016-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e48bf87cb98199bf6adee2be97377c69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3295ab49c310e6219c5218db6b35b902
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63f1fed75b4b448e4f411d74affeb80a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4de66228b814beee2baf8dd588c94a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83c2b2397caf475a06057887fcccf970
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c963f1e8f5b1d9de39853d9845564e3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_608e9a609dbdc4d0c48964daad66775e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb961bf75c74fba1cc879e9466d134e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd280e36d0c9cbc3404ec7ea57c409fb |
| publicationDate |
2017-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2630647-C1 |
| titleOfInvention |
Humanized antibody to conformational c3 epitope constituent of human complement, dna sequence (versions), expression vector containing dna sequence (versions), and ovarian cells' strain of chinese hamster cho-humc34-producer of this humanized antibody |
| abstract |
FIELD: biotechnology. n SUBSTANCE: invention relates to a humanized antibody, which binds to the C3 epitope of the human complement component. DNA encoding the mentioned antibody, an expression vector, for expressing the mentioned antibody, and also a ovarian cells' strain of chinese hamster which produces the mentioned antibody are also disclosed. n EFFECT: invention has the ability to bind specifically to the C3 epitope of the human complement component, which allows the effective treatment of diseases associated with the C3 component of the human complement. n 12 cl, 6 dwg, 3 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2687609-C1 |
| priorityDate |
2016-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |